Hyung Sik Won

Title: Innovations of Hyung Sik Won in Cancer Treatment

Introduction

Hyung Sik Won is a notable inventor based in Chungju-si, South Korea. He has made significant contributions to the field of cancer treatment through his innovative research and patented inventions. His work focuses on developing peptides that have anticancer activity, which can potentially revolutionize cancer therapy.

Latest Patents

Hyung Sik Won holds a patent for a peptide that exhibits anticancer properties. The patent describes a pharmaceutical composition and dietary supplement composition for preventing and treating cancer, both containing a peptide that binds to the transcription factor CP2c. This peptide, represented by SEQ ID NO: 1: Asn-Tyr-Pro-Gln-Arg-Pro, has the ability to pass through cell membranes with high stability. It specifically binds to CP2c, inhibiting its DNA binding ability and disrupting cancer cell-specific transcriptional activity. This innovative approach allows for targeted treatment of cancer cells, making it a promising option for cancer prevention and dietary supplementation.

Career Highlights

Hyung Sik Won is affiliated with the Industry-University Cooperation Foundation at Hanyang University. His work in this institution has allowed him to collaborate with other researchers and contribute to advancements in medical science. His dedication to research and innovation has positioned him as a key figure in the development of new cancer therapies.

Collaborations

Hyung Sik Won has worked alongside notable colleagues, including Chul Geun Kim and Min Young Kim. Their collaborative efforts have further enhanced the research and development of effective cancer treatments.

Conclusion

Hyung Sik Won's innovative work in developing peptides for cancer treatment showcases his commitment to advancing medical science. His patented inventions hold the potential to significantly impact cancer therapy and prevention.